Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer

被引：0
|
作者：
Qifei He
Jiahui Chen
Kai Zhou
Chenggen Jin
Anqiang Wang
Ke Ji
Xin Ji
Ji Zhang
Xiaojiang Wu
Xia Li
Zhaode Bu
Jiafu Ji
机构：
[1] Peking University Cancer Hospital and Institute,Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)
[2] Karolinska Institutet,Department of Medical Epidemiology and Biostatistics
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4413 / 4422
页数：9
相关论文
共 50 条
  • [31] Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
    Gabriella Mariani
    Angelica Fasolo
    Elena De Benedictis
    Luca Gianni
    Nature Clinical Practice Oncology, 2009, 6 : 93 - 104
  • [32] Treatment strategies for patients with HER2-positive gastric cancer
    Feixue Wang
    Yi Ba
    Cancer Biology & Medicine, 2023, 20 (12) : 934 - 941
  • [33] Treatment strategies for patients with HER2-positive gastric cancer
    Wang, Feixue
    Ba, Yi
    CANCER BIOLOGY & MEDICINE, 2023, 20 (12) : 934 - 941
  • [34] Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer
    Ock, Chan-Young
    Lee, Keun-Wook
    Kim, Jin Won
    Kim, Jin-Soo
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Kim, Woo Ho
    Bang, Yung-Jue
    Oh, Do-Youn
    CLINICAL CANCER RESEARCH, 2015, 21 (11) : 2520 - 2529
  • [35] Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective
    Aoki, Masahiko
    Iwasa, Satoru
    Boku, Narikazu
    GASTRIC CANCER, 2021, 24 (03) : 567 - 576
  • [36] Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective
    Masahiko Aoki
    Satoru Iwasa
    Narikazu Boku
    Gastric Cancer, 2021, 24 : 567 - 576
  • [37] Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
    Untch, Michael
    Rezai, Mahdi
    Loibl, Sibylle
    Fasching, Peter A.
    Huober, Jens
    Tesch, Hans
    Bauerfeind, Ingo
    Hilfrich, Joern
    Eidtmann, Holger
    Gerber, Bernd
    Hanusch, Claus
    Kuehn, Thorsten
    du Bois, Andreas
    Blohmer, Jens-Uwe
    Thomssen, Christoph
    Costa, Serban Dan
    Jackisch, Christian
    Kaufmann, Manfred
    Mehta, Keyur
    von Minckwitz, Gunter
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2024 - 2031
  • [38] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [39] The use of trastuzumab in Japanese patients with HER2-positive advanced or metastatic gastric cancer
    Sawaki, A.
    Ohashi, Y.
    Omuro, Y.
    Satoh, T.
    Hamamoto, Y.
    Boku, N.
    Miyata, Y.
    Takiuchi, H.
    Ohtsu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [40] Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer
    Kufel-Grabowska, Joanna
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (05): : 377 - 381
12345